Literature DB >> 8731518

Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: comparison to obsessive compulsive disorder and normal controls.

P Chappell1, J Leckman, W Goodman, G Bissette, D Pauls, G Anderson, M Riddle, L Scahill, C McDougle, D Cohen.   

Abstract

Stress- and anxiety-related fluctuations in tic severity are cardinal features of Tourette's syndrome (TS), and there is evidence for involvement of noradrenergic mechanisms in the pathophysiology and treatment of the disorder. To examine further the pathobiology of this enhanced vulnerability to stress and anxiety, we measured central activity of corticotropin-releasing factor (CRF) in patients with TS and the related condition, obsessive compulsive disorder (OCD). Lumbar cerebrospinal fluid (CSF) was obtained in a standardized fashion for measurement of CRF from 21 medication-free outpatients with TS, 20 with OCD, and 29 healthy controls. The TS patients had significantly higher levels of CSF CRF than both the normal controls and the OCD patients. However, there was no difference in CSF CRF between the OCD patients and the normal controls. Group differences in CSF CRF were unrelated to current clinical ratings of depression, anxiety, tics, and obsessive compulsive behaviors. Although the functional significance of this finding remains to be elucidated, these results are consistent with the hypothesis that stress-related neurobiological mechanisms may play a role in the pathobiology of TS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8731518     DOI: 10.1016/0006-3223(95)00221-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  20 in total

Review 1.  Neurobiological substrates of Tourette's disorder.

Authors:  James F Leckman; Michael H Bloch; Megan E Smith; Daouia Larabi; Michelle Hampson
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-08       Impact factor: 2.576

2.  Interaction between the effects of corticotropin-releasing factor and prepulse parameters on prepulse inhibition in two inbred rat strains and the F1 generation of a cross between them.

Authors:  Lisa H Conti; Jane E Sutherland; Carey M Muhlhauser
Journal:  Behav Brain Res       Date:  2009-06-08       Impact factor: 3.332

3.  Examining cortisol rhythmicity and responsivity to stress in children with Tourette syndrome.

Authors:  B A Corbett; S P Mendoza; C L Baym; S A Bunge; S Levine
Journal:  Psychoneuroendocrinology       Date:  2008-05-19       Impact factor: 4.905

Review 4.  Role of corticotropin releasing factor in anxiety disorders: a translational research perspective.

Authors:  Victoria B Risbrough; Murray B Stein
Journal:  Horm Behav       Date:  2006-07-25       Impact factor: 3.587

Review 5.  What makes you tic? Translational approaches to study the role of stress and contextual triggers in Tourette syndrome.

Authors:  Sean C Godar; Marco Bortolato
Journal:  Neurosci Biobehav Rev       Date:  2016-12-08       Impact factor: 8.989

6.  No association of the norepinephrine transporter gene (SLC6A2) and cognitive and behavioural phenotypes of patients with autism spectrum disorder.

Authors:  Subin Park; Jong-Eun Park; Soo-Churl Cho; Bung-Nyun Kim; Min-Sup Shin; Jae-Won Kim; In Hee Cho; Soon Ae Kim; Mira Park; Tae-Won Park; Jung-Woo Son; Un-Sun Chung; Hee Jeong Yoo
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-01-01       Impact factor: 5.270

7.  Influence of comorbid obsessive-compulsive symptoms on brain event-related potentials in Gilles de la Tourette syndrome.

Authors:  Geneviève Thibault; Mihaela Felezeu; Kieron P O'Connor; Christo Todorov; Emmanuel Stip; Marc E Lavoie
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-02-14       Impact factor: 5.067

Review 8.  Immunopathogenic mechanisms in tourette syndrome: A critical review.

Authors:  Davide Martino; Russell C Dale; Donald L Gilbert; Gavin Giovannoni; James F Leckman
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

9.  PET Imaging of CRF1 with [11C]R121920 and [11C]DMP696: is the target of sufficient density?

Authors:  Gregory M Sullivan; Ramin V Parsey; J S Dileep Kumar; Victoria Arango; Suham A Kassir; Yung-Yu Huang; Norman R Simpson; Ronald L Van Heertum; J John Mann
Journal:  Nucl Med Biol       Date:  2007-03-30       Impact factor: 2.408

10.  Decreased sleep quality and increased sleep related movements in patients with Tourette's syndrome.

Authors:  S Cohrs; T Rasch; S Altmeyer; J Kinkelbur; T Kostanecka; A Rothenberger; E Rüther; G Hajak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.